Abstract
Background Stroke survivors usually have many vascular risk factors (VRFs), and recent studies have reported the association of VRFs with cognitive decline among stroke survivors, which are also associated with PD risk. Therefore, we aimed to investigate how VRFs influenced the risk of PD occurrence in individuals with stroke.
Methods The Korean National Health Insurance Service database was used. We selected individuals who experienced new-onset stroke (ICD-10: I60-I64) between 2008 and 2016 and followed up until 2019. PD was diagnosed according to ICD-10 code G20 and rare and intractable disease registration code V124. Lifestyle factors were collected using self-reported questionnaires, and comorbidities were defined based on ICD-10 codes, medication, and laboratory and anthropometric findings. Cox proportional hazard analyses were conducted to evaluate the association of VRFs with PD incidence among stroke survivors.
Results Among 284,799 stroke survivors, 3,274 cases of PD were reported over a median follow-up period of 5.04 years. In individuals with a history of stroke, smoking (former smoking, hazard ratio (HR) = 0.80, 95% confidence interval (CI), 0.72–0.88; current smoking, HR = 0.66, 95% CI, 0.58–0.76) and alcohol consumption (moderate drinking, HR = 0.83, 95% CI, 0.75–0.91; heavy drinking, HR = 0.74, 95% CI, 0.59–0.94) were associated with a decreased risk of PD. Physically active individuals who had a stroke showed a reduced trend for PD occurrence (P = 0.0508). As for the association between comorbidities and the PD risk, the PD risk increased among stroke survivors with diabetes mellitus (P for trend <.001), particularly in those with a duration of diabetes mellitus of ≥5 years (HR = 1.38, 95% CI, 1.25–1.52).
Conclusions Our results suggest that VRFs are associated with PD occurrence among stroke survivors. Understanding and managing VRFs in relation to PD risk is needed for disease management after stroke.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This study was approved by the Institutional Review Board of Yonsei University Severance Hospital (4-2023-1428), which waived the need for informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
yes
Non-standard Abbreviations and Acronyms
- VRF
- vascular risk factors
- PD
- Parkinson’s disease
- HTN
- hypertension
- DM
- diabetes mellitus
- BP
- blood pressure
- NHIS
- National Health Insurance Service
- ICD
- International Classification of Diseases
- NHSP
- National Health Screening Program
- TC
- total cholesterol
- MBI
- Modified Barthel Index
- HR
- hazard ratio
- CI
- confidence interval
- SES
- socioeconomic status
